Načítá se...
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
There is substantial heterogeneity in the clinical behavior of pancreatic cancer and in its response to therapy. Some of this variation may be due to differences in delivery of cytotoxic therapies between patients and within individual tumors. Indeed, in 12 patients with resectable pancreatic cancer...
Uloženo v:
| Vydáno v: | Phys Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4266401/ https://ncbi.nlm.nih.gov/pubmed/25427073 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1088/1478-3975/11/6/065002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|